Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Obesity11722 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A06840 | 32728158 | Sci Rep | Fatty acid mimetic PBI-4547 restores metabolic homeostasis via GPR84 in mice with non-alcoholic fatty liver disease. | 2020 | Details |
| A06841 | 32727662 | Gastroenterol Hepatol | COVID-19 and liver disease: An update. | 2020 | Details |
| A06842 | 32727275 | Biodemography Soc Biol | Obesity and metabolic outcomes in a safety-net health system. | 2020 | Details |
| A06846 | 32725250 | Acta Derm Venereol | Hidradenitis Suppurativa is Associated with Non-alcoholic Fatty Liver Disease: A Cross-sectional Study. | 2020 | Details |
| A06857 | 32720262 | Obes Surg | Bariatric Surgery in the Setting of Liver Cirrhosis with Portal Hypertension: the Confection and Particularities of Roux-en-Y Gastric Bypass in a High-Risk Patient. | 2020 | Details |
| A06871 | 32715793 | Expert Rev Gastroenterol Hepatol | Noninvasive diagnostic tools for pediatric NAFLD: where are we now? | 2020 | Details |
| A06879 | 32712103 | Gastroenterology | Progression of Fatty Liver Disease in Children Receiving Standard of Care Lifestyle Advice. | 2020 | Details |
| A06882 | 32711187 | Transl Res | The GLP-1R agonist liraglutide limits hepatic lipotoxicity and inflammatory response in mice fed a methionine-choline deficient diet. | 2020 | Details |
| A06884 | 32710880 | Arch Biochem Biophys | Eicosapentaenoic acid-containing polar lipids from seaweed Susabinori (Pyropia yezoensis) alleviate hepatic steatosis in obese db/db mice. | 2020 | Details |
| A06886 | 32710190 | Diabetologia | Multi-layered epigenetic regulation of IRS2 expression in the liver of obese individuals with type 2 diabetes. | 2020 | Details |
| A06888 | 32708435 | Nutrients | Baseline HOMA IR and Circulating FGF21 Levels Predict NAFLD Improvement in Patients Undergoing a Low Carbohydrate Dietary Intervention for Weight Loss: A Prospective Observational Pilot Study. | 2020 | Details |
| A06892 | 32707340 | Clin Gastroenterol Hepatol | Association of Hepatic Steatosis With Major Adverse Cardiovascular Events, Independent of Coronary Artery Disease. | 2020 | Details |
| A06909 | 32700545 | Biol Res Nurs | Oral Probiotic Bifidobacterium Longum Supplementation Improves Metabolic Parameters and Alters the Expression of the Renin-Angiotensin System in Obese Mice Liver. | 2020 | Details |
| A06925 | 32696080 | Clin Res Cardiol | NAFLD and cardiovascular diseases: a clinical review. | 2020 | Details |
| A06928 | 32695733 | Can J Gastroenterol Hepatol | Verification of the Nutritional and Dietary Factors Associated with Skeletal Muscle Index in Japanese Patients with Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A06930 | 32694843 | Nat Metab | Hepatic Rab24 controls blood glucose homeostasis via improving mitochondrial plasticity. | 2019 | Details |
| A06932 | 32694791 | Nat Metab | The small intestine shields the liver from fructose-induced steatosis. | 2020 | Details |
| A06938 | 32692879 | Mol Nutr Food Res | Inflammatory Diseases and Vitamin E-What Do We Know and Where Do We Go? | 2020 | Details |
| A06941 | 32691524 | Obes Rev | Diet-induced rodent models of obesity-related metabolic disorders-A guide to a translational perspective. | 2020 | Details |
| A06944 | 32690594 | J Lipid Res | Depletion of adipocyte sphingosine kinase 1 leads to cell hypertrophy, impaired lipolysis, and nonalcoholic fatty liver disease. | 2020 | Details |
| A06947 | 32690183 | Clin Nutr ESPEN | A significant association of non-obese non-alcoholic fatty liver disease with sarcopenic obesity. | 2020 | Details |
| A06948 | 32690182 | Clin Nutr ESPEN | Non-alcoholic fatty liver disease (NAFLD) among underweight adults. | 2020 | Details |
| A06949 | 32690164 | Clin Nutr ESPEN | Effect of lifestyle modification education based on health belief model in overweight/obese patients with non-alcoholic fatty liver disease: A parallel randomized controlled clinical trial. | 2020 | Details |
| A06952 | 32688217 | J Nutr Biochem | Epigallocatechin gallate but not catechin prevents nonalcoholic steatohepatitis in mice similar to green tea extract while differentially affecting the gut microbiota. | 2020 | Details |
| A06954 | 32687673 | Pediatr Int | Pediatric non-alcoholic fatty liver disease predicted by anthropometric values through transient elastography. | 2021 | Details |
| A06957 | 32687159 | J Clin Endocrinol Metab | Sex-Specific Metabolite Biomarkers of NAFLD in Youth: A Prospective Study in the EPOCH Cohort. | 2020 | Details |
| A06958 | 32686578 | Expert Opin Emerg Drugs | Emerging drugs for the treatment of non-alcoholic steatohepatitis: a focused review of farnesoid X receptor agonists. | 2020 | Details |
| A06959 | 32686456 | Rev Esp Enferm Dig | What may GLP1 receptor agonists contribute to the treatment of patients with non-alcoholic fatty liver disease? | 2020 | Details |
| A06961 | 32685936 | Explor Med | Nonalcoholic fatty liver disease and portal hypertension. | 2020 | Details |
| A06963 | 32685107 | World J Hepatol | Comparison of four non-alcoholic fatty liver disease detection scores in a Caucasian population. | 2020 | Details |
| A06964 | 32684985 | Diabetol Metab Syndr | NAFLD as a continuum: from obesity to metabolic syndrome and diabetes. | 2020 | Details |
| A06966 | 32684526 | Endocr J | Association between hemoglobin levels and non-alcoholic fatty liver disease in patients with young-onset type 2 diabetes mellitus. | 2020 | Details |
| A06968 | 32683952 | Am J Physiol Gastrointest Liver Physiol | Knockout of sulfatase 2 is associated with decreased steatohepatitis and fibrosis in a mouse model of nonalcoholic fatty liver disease. | 2020 | Details |
| A06974 | 32681291 | Obes Surg | 1-Year Follow-up of Single Anastomosis Sleeve Ileal (SASI) Bypass in Morbid Obese Patients: Efficacy and Concerns. | 2020 | Details |
| A06976 | 32679761 | Biomolecules | Untargeted Profiling of Bile Acids and Lysophospholipids Identifies the Lipid Signature Associated with Glycemic Outcome in an Obese Non-Diabetic Clinical Cohort. | 2020 | Details |
| A06977 | 32679195 | Arch Biochem Biophys | (-)-Epicatechin and the comorbidities of obesity. | 2020 | Details |
| A06981 | 32674529 | Clin Mol Hepatol | Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH. | 2020 | Details |
| A06986 | 32671767 | Adv Exp Med Biol | Autophagy and Obesity and Diabetes. | 2020 | Details |
| A06989 | 32671089 | Front Nutr | A Description of Risk Factors for Non-alcoholic Fatty Liver Disease in the Southern Community Cohort Study: A Nested Case-Control Study. | 2020 | Details |
| A06995 | 32667128 | J Diabetes | Effect of exercise on hepatic steatosis: Are benefits seen without dietary intervention? A systematic review and meta-analysis. | 2020 | Details |
| A06997 | 32666779 | Pol Arch Intern Med | Nonalcoholic fatty liver disease and the risk of metabolic comorbidities: how to manage in clinical practice. | 2020 | Details |
| A06998 | 32666675 | Liver Int | Hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy: The emerging role of non-viral risk factors. | 2020 | Details |
| A06999 | 32666604 | FASEB J | Liver CPT1A gene therapy reduces diet-induced hepatic steatosis in mice and highlights potential lipid biomarkers for human NAFLD. | 2020 | Details |
| A07001 | 32664383 | Antioxidants (Basel) | The Interplay between Oxidative Stress and miRNAs in Obesity-Associated Hepatic and Vascular Complications. | 2020 | Details |
| A07007 | 32660189 | Zhonghua Gan Zang Bing Za Zhi | [Pancreatoduodenectomy and non-alcoholic fatty liver disease]. | 2020 | Details |
| A07011 | 32660130 | Metabolites | Transcriptional Regulation in Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A07012 | 32659827 | Z Gastroenterol | [Choosing wisely - perspectives: what are the key questions?] | 2020 | Details |
| A07014 | 32657670 | J Am Coll Nutr | Hepatoprotective Effect of Antrodia cinnamomea Mycelium in Patients with Nonalcoholic Steatohepatitis: A Randomized, Double-Blind, Placebo-Controlled Trial. | 2020 | Details |
| A07015 | 32657010 | Obesity (Silver Spring) | Hepatocyte Notch Signaling Deregulation Related to Lipid Metabolism in Women with Obesity and Nonalcoholic Fatty Liver. | 2020 | Details |
| A07025 | 32654390 | Liver Int | The association of non-alcoholic fatty liver disease and cardiac structure and function-Framingham Heart Study. | 2020 | Details |
| A07026 | 32654086 | Dig Dis Sci | Nonalcoholic Fatty Liver Disease Risk Factors Affect Liver-Related Outcomes After Direct-Acting Antiviral Treatment for Hepatitis C. | 2020 | Details |
| A07028 | 32652799 | Liver Int | High-protein diet more effectively reduces hepatic fat than low-protein diet despite lower autophagy and FGF21 levels. | 2020 | Details |
| A07031 | 32651233 | J Biol Chem | From overnutrition to liver injury: AMP-activated protein kinase in nonalcoholic fatty liver diseases. | 2020 | Details |
| A07033 | 32650421 | Cells | Peroxisome Proliferator-Activated Receptors and Their Novel Ligands as Candidates for the Treatment of Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A07036 | 32649794 | Acta Paediatr | Prevalence of elevated liver enzymes and comorbidities in children and adolescents with overweight and obesity. | 2020 | Details |
| A07037 | 32649507 | Chin Med J (Engl) | Intestinal epithelial chemokine (C-C motif) ligand 7 overexpression protects against high fat diet-induced obesity and hepatic steatosis in mice. | 2020 | Details |
| A07048 | 32643194 | Prenat Diagn | Perinatal exposure to maternal obesity: Lasting cardiometabolic impact on offspring. | 2020 | Details |
| A07049 | 32642003 | Theranostics | Current understanding of the role of Adipose-derived Extracellular Vesicles in Metabolic Homeostasis and Diseases: Communication from the distance between cells/tissues. | 2020 | Details |
| A07052 | 32640331 | Food Chem Toxicol | Analysis of the intricate effects of polyunsaturated fatty acids and polyphenols on inflammatory pathways in health and disease. | 2020 | Details |
| A07053 | 32640105 | J Intern Med | A systems biology approach to understand gut microbiota and host metabolism in morbid obesity: design of the BARIA Longitudinal Cohort Study. | 2020 | Details |
| A07054 | 32639223 | Int J Vitam Nutr Res | Vitamin D levels are not associated with non-alcoholic fatty liver disease severity in a Brazilian population. | 2020 | Details |
| A07055 | 32638913 | Rev Col Bras Cir | Comparison of the severity of non-alcoholic fatty liver disease in diabetic and non-diabetic obese patients. | 2020 | Details |
| A07056 | 32638543 | Pediatr Obes | Significance of autoantibody seropositivity in children with obesity and non-alcoholic fatty liver disease. | 2020 | Details |
| A07057 | 32638541 | J Cachexia Sarcopenia Muscle | Association between muscle strength and advanced fibrosis in non-alcoholic fatty liver disease: a Korean nationwide survey. | 2020 | Details |
| A07065 | 32634767 | J Trace Elem Med Biol | The sex-specific effects of blood lead, mercury, and cadmium levels on hepatic steatosis and fibrosis: Korean nationwide cross-sectional study. | 2020 | Details |
| A07067 | 32634278 | J Intern Med | Liver mitochondrial DNA damage and genetic variability of Cytochrome b - a key component of the respirasome - drive the severity of fatty liver disease. | 2020 | Details |
| A07070 | 32632389 | Transl Gastroenterol Hepatol | Acute-on-chronic liver failure in liver transplant candidates with non-alcoholic steatohepatitis. | 2020 | Details |
| A07071 | 32632387 | Transl Gastroenterol Hepatol | Pathogenesis of non-alcoholic fatty liver disease and implications on cardiovascular outcomes in liver transplantation. | 2020 | Details |
| A07074 | 32631250 | BMC Gastroenterol | Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis. | 2020 | Details |
| A07077 | 32630610 | Biomedicines | Risk Factors Contributing to the Occurrence and Recurrence of Hepatocellular Carcinoma in Hepatitis C Virus Patients Treated with Direct-Acting Antivirals. | 2020 | Details |
| A07079 | 32630407 | Diagnostics (Basel) | Accuracy of a Semi-Quantitative Ultrasound Method to Determine Liver Fat Infiltration in Early Adulthood. | 2020 | Details |
| A07082 | 32629394 | EBioMedicine | MBOAT7 down-regulation by genetic and environmental factors predisposes to MAFLD. | 2020 | Details |
| A07084 | 32629123 | Clin Gastroenterol Hepatol | Lean Americans With Nonalcoholic Fatty Liver Disease Have Lower Rates of Cirrhosis and Comorbid Diseases. | 2020 | Details |
| A07085 | 32628898 | United European Gastroenterol J | Metabolic endoscopy: Today's science-tomorrow's treatment. | 2020 | Details |
| A07089 | 32626837 | Hepatol Commun | Activation of Adenosine Monophosphate-Activated Protein Kinase Reduces the Onset of Diet-Induced Hepatocellular Carcinoma in Mice. | 2020 | Details |
| A07094 | 32625166 | Front Endocrinol (Lausanne) | Serum Ferritin Correlates With Liver Fat in Male Adolescents With Obesity. | 2020 | Details |
| A07096 | 32623632 | Hepatol Int | Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study). | 2020 | Details |
| A07101 | 32622088 | Biochim Biophys Acta Mol Cell Biol Lipids | The "discovery" of lipid droplets: A brief history of organelles hidden in plain sight. | 2020 | Details |
| A07107 | 32621046 | Cardiovasc Drugs Ther | Prolonged-release pirfenidone prevents obesity-induced cardiac steatosis and fibrosis in a mouse NASH model. | 2021 | Details |
| A07109 | 32620521 | Dig Liver Dis | Suppression of high-fat diet-induced obesity-associated liver mitochondrial dysfunction by docosahexaenoic acid and hydroxytyrosol co-administration. | 2020 | Details |
| A07111 | 32619031 | Diabet Med | Mechanisms, screening modalities and treatment options for individuals with non-alcoholic fatty liver disease and type 2 diabetes. | 2020 | Details |
| A07112 | 32618656 | Am J Gastroenterol | Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improves Abnormal Small Intestinal Permeability: A Randomized Control Trial. | 2020 | Details |
| A07116 | 32617026 | Hepat Med | Effect of Oral Administration of Weissella confusa on Fecal and Plasma Ethanol Concentrations, Lipids and Glucose Metabolism in Wistar Rats Fed High Fructose and Fat Diet. | 2020 | Details |
| A07126 | 32612827 | SAGE Open Med | Nonalcoholic fatty liver disease and cardiovascular disease phenotypes. | 2020 | Details |
| A07132 | 32607889 | Methods Mol Biol | An Obesogenic Dietary Mouse Model of Nonalcoholic Steatohepatitis. | 2020 | Details |
| A07133 | 32607888 | Methods Mol Biol | In Vivo Investigation of High-Fat Diet-Induced Hepatic Lipid Dysfunctions. | 2020 | Details |
| A07134 | 32607879 | Methods Mol Biol | Liver Macrophage Isolation by Flow Cytometry Sorting. | 2020 | Details |
| A07140 | 32605642 | BMC Endocr Disord | Impact of obesity and metabolic health status in the development of non-alcoholic fatty liver disease (NAFLD): A United Kingdom population-based cohort study using the health improvement network (THIN). | 2020 | Details |
| A07141 | 32605253 | Cancers (Basel) | Current and Future Treatments in the Fight Against Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A07148 | 32602214 | Hepatol Res | Clinical and anthropometric characteristics of non-obese non-alcoholic fatty liver disease subjects in Japan. | 2020 | Details |
| A07149 | 32599713 | Int J Mol Sci | Fructose and Uric Acid: Major Mediators of Cardiovascular Disease Risk Starting at Pediatric Age. | 2020 | Details |
| A07158 | 32597296 | Autophagy | The unfolded protein response regulates hepatic autophagy by sXBP1-mediated activation of TFEB. | 2020 | Details |
| A07160 | 32595949 | F1000Res | Dyslipidemia as a risk factor for liver fibrosis progression in a multicentric population with non-alcoholic steatohepatitis. | 2020 | Details |
| A07165 | 32595023 | Obes Res Clin Pract | Pro-inflammatory HDL in women with obesity and nonalcoholic steatohepatitis. | 2020 | Details |
| A07166 | 32594969 | J Dev Orig Health Dis | Post-weaning exposure to high-sucrose diet induces early non-alcoholic fatty liver disease onset and progression in male mice: role of dysfunctional white adipose tissue. | 2020 | Details |
| A07167 | 32594797 | Hypertension | Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in US Adults Across Blood Pressure Categories. | 2020 | Details |
| A07171 | 32593710 | Life Sci | Bisphenol-A exposure worsens hepatic steatosis in ovariectomized mice fed on a high-fat diet: Role of endoplasmic reticulum stress and fibrogenic pathways. | 2020 | Details |
| A07176 | 32592532 | Phytother Res | Sophoricoside is a selective LXRβ antagonist with potent therapeutic effects on hepatic steatosis of mice. | 2020 | Details |
| A07190 | 32588069 | Naunyn Schmiedebergs Arch Pharmacol | In vitro targeted screening and molecular docking of stilbene, quinones, and flavonoid on 3T3-L1 pre-adipocytes for anti-adipogenic actions. | 2020 | Details |
| A07191 | 32587654 | J Clin Med Res | Associations Between Cannabis Use, Abdominal Fat Phenotypes and Insulin Traits. | 2020 | Details |